
Luke Maese, DO, discusses treatment considerations for asparaginase-containing regimens in adult and young adult patients with ALL.

Your AI-Trained Oncology Knowledge Connection!


Luke Maese, DO, is an associate professor at the University of Utah School of Medicine; director of the Pediatric Leukemia/Lymphoma and Pediatric Cancer Genetics programs, director of the Clinical Trial Research Enterprise, and co-director of the Bone Marrow Failure program in the Division of Pediatric Hematology/Oncology at the University of Utah Primary Children’s Hospital; and a member of the Family Cancer Assessment Clinic at the University of Utah Huntsman Cancer Institute

Published: August 4th 2025 | Updated: